OssDsign: CEO transition planned for H2 2025 - SEB
Idag, 10:02
Idag, 10:02
OssDsign announced the CEO transition is planned for H2/25, where Morten Henneveld will step down at end-2025. Its aim is to establish leadership, with an even stronger presence in and focus on the US market where OssDsign has 100% of net sales. Mr. Henneveld has been instrumental in transitioning OssDsign from an EU cranial patient-specific implant company to a US-focused orthobiologics company with scaling opportunities. We see no drama and agree with the US importance.
SEB Research
This research has been commissioned by the company. Only for professional investors resident in EEA member states. Reports may not be distributed to the US or other jurisdictions where to do so would be unlawful. Please see the disclaimer tab for any details of investment banking services recently provided by SEB that could be considered relevant to the subject matter of this research.
Idag, 10:02
OssDsign announced the CEO transition is planned for H2/25, where Morten Henneveld will step down at end-2025. Its aim is to establish leadership, with an even stronger presence in and focus on the US market where OssDsign has 100% of net sales. Mr. Henneveld has been instrumental in transitioning OssDsign from an EU cranial patient-specific implant company to a US-focused orthobiologics company with scaling opportunities. We see no drama and agree with the US importance.
SEB Research
This research has been commissioned by the company. Only for professional investors resident in EEA member states. Reports may not be distributed to the US or other jurisdictions where to do so would be unlawful. Please see the disclaimer tab for any details of investment banking services recently provided by SEB that could be considered relevant to the subject matter of this research.
Rapportperioden
Placera granskar fondjättarna
Analytikerna om Volvo Cars
Analys
Rapportperioden
Placera granskar fondjättarna
Analytikerna om Volvo Cars
Analys
OMX Stockholm 30
1 DAG %
Senast
2 434,06